Literature DB >> 3876006

Expandable intrahepatic portacaval shunt stents: early experience in the dog.

J C Palmaz, R R Sibbitt, S R Reuter, F Garcia, F O Tio.   

Abstract

Intrahepatic portacaval shunts were established in dogs by the transjugular approach. The shunts extended from the anterior aspect of the inferior vena cava to the portal bifurcation through interposed liver parenchyma. The tissue track was created by a long transjugular needle and enlarged by balloon angioplasty catheter dilatation. The opening was then stented with a specially made, expandable, tubular, woven mesh of stainless steel wire. The stent was introduced mounted in a collapsed fashion around a folded angioplasty balloon. Inflation of the balloon expanded the stent and the tissue track simultaneously, leaving a large side-to-side portacaval shunt. Nine out of 12 animals survived the procedure and eight of them had functioning shunts as long as 9 months after placement. Pathologic examination showed complete endothelialization of the inner surface of the stents.

Entities:  

Mesh:

Year:  1985        PMID: 3876006     DOI: 10.2214/ajr.145.4.821

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Intravascular stenting: from basic research to clinical application.

Authors:  J C Palmaz
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Historical overview on the development and characteristics of stents and future outlooks.

Authors:  C L Zollikofer; F Antonucci; G Stuckmann; P Mattias; E K Salomonowitz
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Transjugular intrahepatic portocaval shunt (TIPS) and hepatic vein-to-caval stenting as salvage treatment of portal hypertension secondary to neoplasm.

Authors:  R P Davies; G R Sissons; N A McIntosh
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Mar-Apr       Impact factor: 2.740

4.  Efficacy of Doppler ultrasonography for assessment of transjugular intrahepatic portosystemic shunt patency.

Authors:  M Kimura; M Sato; N Kawai; K Tanaka; T Sonomura; K Kishi; Y Shioyama; M Terada; R Yamada
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

Review 5.  Intravascular stent therapy for coarctation of the aorta.

Authors:  Thomas J Forbes; Srinath T Gowda
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

Review 6.  Current status and future possibilities of transjugular intrahepatic portosystemic shunts in the management of portal hypertension.

Authors:  P M Radosevich; J M LaBerge; R L Gordon
Journal:  World J Surg       Date:  1994 Sep-Oct       Impact factor: 3.352

Review 7.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study.

Authors:  H Rousseau; J P Vinel; J I Bilbao; J M Longo; P Maquin; J M Zozaya; L Garcia-Villareal; B Coustet; N Railhac; J J Railhac
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

9.  Use of balloon-expandable stents to treat experimental peripheral pulmonary artery and superior vena caval stenosis: preliminary experience.

Authors:  A P Rocchini; J N Meliones; R H Beekman; C Moorehead; M London
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

10.  Transjugular intrahepatic portasystemic stent shunting for control of acute and recurrent upper gastrointestinal haemorrhage related to portal hypertension.

Authors:  K J Simpson; N Chalmers; D N Redhead; N D Finlayson; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.